We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAN icon
1226
ManpowerGroup
MAN
$2.63B
$201K 0.03%
3,109
-3,959
-56% -$298K
IPG
1227
DELISTED
Interpublic Group of Companies
IPG
$200K 0.03%
+7,827
New +$222K
TBHC
1228
DELISTED
The Brand House Collective
TBHC
$200K 0.03%
+66,467
New +$256K
PBI icon
1229
Pitney Bowes
PBI
$2.39B
$200K 0.03%
85,659
-50,919
-37% -$163K
BYND icon
1230
Beyond Meat
BYND
$277M
$199K 0.03%
+14,046
New +$387K
HBIO icon
1231
Harvard Bioscience
HBIO
$29.2M
$199K 0.03%
+7,782
New +$257K
KURA icon
1232
Kura Oncology
KURA
$850M
$198K 0.03%
+14,497
New +$224K
PUBM icon
1233
PubMatic
PUBM
$810M
$198K 0.03%
+11,916
New +$215K
IONQ icon
1234
IonQ
IONQ
$16.6B
$196K 0.03%
38,574
+27,589
+251% +$153K
VYX icon
1235
NCR Voyix
VYX
$1.14B
$194K 0.03%
+16,672
New +$306K
FDMT icon
1236
4D Molecular Therapeutics
FDMT
$562M
$193K 0.03%
+23,997
New +$217K
ARKO icon
1237
ARKO Corp
ARKO
$635M
$192K 0.03%
+20,419
New +$194K
TELL
1238
DELISTED
Tellurian Inc.
TELL
$192K 0.03%
+80,504
New +$290K
ALTO icon
1239
Alto Ingredients
ALTO
$340M
$191K 0.03%
52,410
-27,853
-35% -$117K
AREC icon
1240
American Resources Corp
AREC
$293M
$190K 0.03%
71,195
-30,250
-30% -$74K
NKTR icon
1241
Nektar Therapeutics
NKTR
$2.58B
$190K 0.03%
3,952
+1,257
+47% +$74.8K
IDEX
1242
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$190K 0.03%
5,533
-1,604
-22% -$121K
LPRO
1243
DELISTED
Open Lending Corp
LPRO
$188K 0.02%
+23,361
New +$236K
PATH icon
1244
UiPath
PATH
$7.8B
$188K 0.02%
+14,927
New +$262K
FWRG icon
1245
First Watch Restaurant Group
FWRG
$766M
$187K 0.02%
+12,902
New +$209K
PKE icon
1246
Park Aerospace
PKE
$819M
$186K 0.02%
+16,831
New +$199K
ECHO
1247
EchoStar
ECHO
$26.2B
$185K 0.02%
+11,238
New +$210K
HGEN
1248
DELISTED
HUMANIGEN, INC.
HGEN
$185K 0.02%
1,026,643
+793,218
+340% +$427K
HYFM icon
1249
Hydrofarm Holdings
HYFM
$7.62M
$184K 0.02%
+9,505
New +$305K
ICAD
1250
DELISTED
iCAD Inc
ICAD
$184K 0.02%
87,701
+74,713
+575% +$245K
48 49
50
51 52

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.